SalaryGuide
AboutPricingFor Employers

Marketing jobs

30 marketing jobs

Bayer logo
1 month ago

Assistant Brand Manager - Consumer Health

Bayer

Reading, UK (Hybrid)Full time£44K/yr – £50K/yr
Experian logo
1 month ago

Product Marketing Executive - Consumer

Experian

London, UK (Hybrid)Full time
the LEGO Group logo
1 month ago

Lead Cyber Security Steward – Consumer Marketing Technology

the LEGO Group

London, UK (Hybrid)Full time
Newsweek logo
1 month ago

Head of Consumer Social

Newsweek

UK (Remote)Full time
2 months ago

Product Marketing Lead - Global Consumer

Wise

London, UK (On-site)Full time£110K/yr – £150K/yr
MARI logo
2 months ago

Consumer Marketing Coordinator, Arts & Entertainment

MARI

UK (Hybrid)Permanent
Plum logo
2 months ago

Consumer PR & Social Media Manager

Plum

London, UK (Hybrid)Full time
Cirkle logo
2 months ago

PR Account Director (Consumer)

Cirkle

London, UK (Hybrid)Full time
Tesco logo
2 months ago

Consumer PR Manager - 12 month Fixed Term Contract

Tesco

Welwyn Garden City, Hertfordshire, UK (Hybrid)Temporary
targetjobs UK logo
2 months ago

Consumer Marketing Manager Graduate (TikTok Shop - Marketing)

targetjobs UK

London, UK (On-site)Full time
Previous
12
Next

All Consumer roles in the UK

Get alerts for this search

All Consumer roles in the UK

Get alerts for this search

30 jobs
Bayer logo

Assistant Brand Manager - Consumer Health

Bayer

Reading, UK (Hybrid)

£44K/yr - £50K/yrIn-houseFull-timeMid level
1 month ago
Experian logo

Product Marketing Executive - Consumer

Experian

London, UK (Hybrid)

In-houseFull-timeMid level
1 month ago
the LEGO Group logo

Lead Cyber Security Steward – Consumer Marketing Technology

the LEGO Group

London, UK (Hybrid)

In-houseFull-timeSenior level
1 month ago
Newsweek logo

Head of Consumer Social

Newsweek

UK (Remote)

In-houseFull-timeSenior level
1 month ago

Product Marketing Lead - Global Consumer

Wise

London, UK (On-site)

£110K/yr - £150K/yrIn-houseFull-timeSenior level
2 months ago
MARI logo

Consumer Marketing Coordinator, Arts & Entertainment

MARI

UK (Hybrid)

In-housePermanentEntry level
2 months ago
Plum logo

Consumer PR & Social Media Manager

Plum

London, UK (Hybrid)

In-houseFull-timeMid level3+ years exp.
2 months ago
Cirkle logo

PR Account Director (Consumer)

Cirkle

London, UK (Hybrid)

AgencyFull-timeSenior level
2 months ago
Tesco logo

Consumer PR Manager - 12 month Fixed Term Contract

Tesco

Welwyn Garden City, Hertfordshire, UK (Hybrid)

In-houseTemporarySenior level
2 months ago
targetjobs UK logo

Consumer Marketing Manager Graduate (TikTok Shop - Marketing)

targetjobs UK

London, UK (On-site)

In-houseFull-timeIntern/new grad
2 months ago
Previous12
Bayer logo
Bayer

Assistant Brand Manager - Consumer Health

Reading, UK (Hybrid)

£44K/yr – £50K/yrMid LevelFull time

Posted 1 month ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own brand activation across channels from plan to rollout, driving content, digital campaigns, and performance metrics while supporting budget and KPI tracking.

  • Brand & Campaign Execution: Deliver brand plans and campaigns across digital, retail, and media channels.
  • Content & Digital Performance: Own content creation and optimise digital campaigns for reach and effectiveness.
  • Insights & Collaboration: Analyse market trends and work with commercial and retail teams to scale initiatives and track KPIs.

Job Description

Own brand activation across channels from plan to rollout, driving content, digital campaigns, and performance metrics while supporting budget and KPI tracking.

  • Brand & Campaign Execution: Deliver brand plans and campaigns across digital, retail, and media channels.
  • Content & Digital Performance: Own content creation and optimise digital campaigns for reach and effectiveness.
  • Insights & Collaboration: Analyse market trends and work with commercial and retail teams to scale initiatives and track KPIs.
Bayer logo

Bayer

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population.At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses.Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world.Data Privacy Statement & Imprint: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint

Founded in 1999
Leverkusen, North Rhine-Westphalia, DEU
96K employees (6,644 in marketing)
www.bayer.com

Traffic Signals

Monthly Visitors
962.4K
Monthly Google Ads Budget
$48.5K
Traffic Source Mix
Search
52.9%
Direct
34.9%
Referral
7.6%
Social
3.6%
Paid
1%

Headcount Trend

Current headcount: ~95.8K

Marketing Team

Marketing Team Size
5,580 (6% of company)
Median Career Experience
16.5 years
Median Tenure
9.1 years
Marketing Roles Posted (Last 30 Days)
7

People

Marketing Leadership

Samantha Avivi
Samantha Avivi
Chief Marketing Officer, Consumer Health
At the company for 2 years 4 months
Amy Hessels
Amy Hessels
VP, Women's Healthcare Marketing
At the company for 11 years 2 months
Nicole Dinello
Nicole Dinello
Vice President, Prostate Marketing at Bayer Pharmaceuticals
At the company for 4 years 1 month
Dennis Kvesić
Dennis Kvesić
Vice President, Global and US Marketing
At the company for 26 years 5 months

Funding

Total Funding
$9.3B
Last Raise
$332.1M
Post IPO Debt, 6 months ago

Funding History

  • Sep 2025
    Post IPO Debt • $332.1M
  • Dec 2024
    Post IPO Debt • $5.3B
  • Nov 2022
    Grant • $12M

Recent News

Lawyers facing big paydays from Tylenol attack | READER COMMENTARY
Sep 28, 2025 • Baltimore Sun
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
Sep 26, 2025 • BioSpace
Global Markets Mixed After Pharmaceutical, Trucks Tariffs Announcement
Sep 26, 2025 • Morningstar.com
European drugmakers' shares hold firm, despite Trump tariffs
Sep 26, 2025 • MarketScreener
Portuguese and multinational companies sign up to the Lisbon Principles to prepare management in the AI era
Sep 26, 2025 • Essential Business
BotCity Secures $12 Million Series A Funding to Address Growing Risks in “Shadow Automation”
Sep 25, 2025 • BotCity
BotCity Secures $12 Million Series A Funding to Address Growing Risks in “Shadow Automation”
Sep 25, 2025 • Venture Capital Firms
Mint Pharmaceuticals Announces Partnership with Bayer Canada to Distribute ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
Sep 25, 2025 • PR Newswire
Neurostim Pain Devices Market to Reach USD 25,477.3 Million by 2035, Driven by Innovation in Chronic Pain Therapy
Sep 25, 2025 • EIN Presswire
Agriculture Biotech Market Size Worth $214.6 Billion by 2031 With CAGR of 8.8%
Sep 24, 2025 • EIN Presswire
Diagnostic Imaging Market Size is Expected to Reach USD 70.02 Bn by 2034 Technological Advancements and Growing Demand for Early Detection Drive Market Growth
Sep 24, 2025 • Precedence Research
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
Sep 23, 2025 • BioSpace
Tylenol parent’s stock rises despite Trump autism claims
Sep 23, 2025 • semafor.com
Market Revenues for Biological and Medical Imaging Reagents to Cross $40 Billion by 2030, Driven by Rising Diagnostic Needs and Advanced Technologies
Sep 23, 2025 • Research and Markets
Bayer's AskBio launches European Phase 2 trial of gene therapy for Parkinson's disease
Sep 23, 2025 • MarketScreener
Bayer Fails to Shed Challenge to Xarelto Patent at Appeals Court
Sep 23, 2025 • bloomberglaw.com
Bill Andersen soll den Dax-Konzern Bayer wieder zum Erfolg führen
Sep 22, 2025 • SZ.de
Bayer starts pivotal Parkinson's cell therapy trial
Sep 22, 2025 • pharmaphorum
Drought Tolerant Seeds Market to Reach USD 192.2 Mn by 2035, Driven by Climate Resilience and Biotechnology Innovation
Sep 19, 2025 • EIN Presswire
Novo's once-weekly combo drug for Type 2 diabetes scores EU endorsement
Sep 19, 2025 • FiercePharma
Bayer strengthens natural health research with advanced phytomedicines lab in Germany
Sep 19, 2025 • EuropaWire
Bayer’s menopause drug wins European regulator backing
Sep 19, 2025 • Investing.com
Bayer - Elinzanetant recommended for approval in EU as treatment of moderate to severe vasomotor symptoms
Sep 19, 2025 • MarketScreener
Regeneron Pharmaceuticals Inc to donate 500 doses of Inmazeb to WHO
Sep 19, 2025 • MarketScreener
Bayer Opens New Phytomedicines Laboratory at German Site
Sep 18, 2025 • MarketScreener
Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs
Sep 18, 2025 • BioSpace
Bayer Says NDA for MRI Contrast Agent Gadoquatrane Accepted in China
Sep 18, 2025 • MarketScreener
Bayer: inaugurates laboratory for herbal medicines
Sep 18, 2025 • MarketScreener
Health for All, Hunger for None: Bijoy Sagar talks about Bayer's AI-First Future Vision on the CAIO Connect Podcast
Sep 17, 2025 • EIN Presswire
Alteogen wins European approval for Eylea biosimilar Eyluxvi
Sep 17, 2025 • Pharma Letter
Bayer begins construction of Berlin Center for Gene and Cell Therapies
Sep 17, 2025 • MarketScreener
Bayer AG Digital Transformation Strategy Report 2025: Accelerators, Incubators, and Innovation Programs
Sep 17, 2025 • Research and Markets
AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)
Sep 17, 2025 • Asklepios BioPharmaceutical, Inc. (AskBio)
Bayer Crop Science Canada Introduces Raxil Rise, A New Standard in Cereal Seed Treatment Français
Sep 17, 2025 • Canada NewsWire
Bayer AG - AskBio announces completion of enrollment in phase 1 clinical trial of AB-1005 gene therapy
Sep 17, 2025 • MarketScreener
Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
Sep 16, 2025 • Parexel International LLC
With Drug Picked Up From Sanofi, Startup AllRock Takes Aim at Two Severe Lung Diseases
Sep 16, 2025 • MedCity News
Measurement is the word defining retail media right now
Sep 16, 2025 • Digiday
Life Sciences Firms Gear Up as Patent Litigation Campaigns Grow
Sep 15, 2025 • bloomberglaw.com
In ‘biotech winter,’ Boston startups, jobs, and science are being swept away
Sep 15, 2025 • Boston Globe
Morgan Stanley says Corteva may want to get out in front of ag landscape changes
Sep 15, 2025 • thefly.com
My father the fraud: Daughter reveals how key scientist in Primodos scandal built career on lies
Sep 14, 2025 • Sky News
Radioligand Therapy (RLT) Market worth US$10.9 billion by 2035 with 13.2% CAGR | MarketsandMarkets™
Sep 13, 2025 • PR Newswire UK
Radioligand Therapy (RLT) Market worth US$10.9 billion by 2035 with 13.2% CAGR | MarketsandMarkets™
Sep 13, 2025 • PR Newswire
The future of St. Louis runs through entrepreneurship
Sep 12, 2025 • Seattle TechFlash
Dewpoint closes Series D to advance first-in-class c-mod into clinical development for gastric cancer
Sep 12, 2025 • Pharma Letter
ONEiO from Finland raises €8M to replace manual IT integrations with always-on IntegrationOps
Sep 12, 2025 • FoundersToday
‘The year where I don’t roll my eyes’ at retail: Bayer’s programmatic and digital lead on the state of retail media
Sep 12, 2025 • Digiday
Tata Elxsi and Bayer Unveil Radiology Development Centre to Fast-Track Diagnostic Innovation
Sep 11, 2025 • Indianweb2.com
Finnish scale-up ONEiO raises €8 million to make manual IT integrations obsolete with IntegrationOps
Sep 11, 2025 • EU-Startups
Animal Biotechnology Market Size to Reach USD 58.23 Billion by 2034, Growing at 11.20% CAGR
Sep 10, 2025 • EIN Presswire
Dewpoint Therapeutics Closes Series D Financing to Advance First-in-Class Condensate Modulator (c-mod) into Clinical Development for Gastric Cancer
Sep 10, 2025 • Dewpoint Therapeutics
MustGrow Secures $2 Million Line of Credit with CIBC; Guaranteed by EDC
Sep 10, 2025 • Newsfile
Tata Elxsi Launches a Global Technology Centre for Medical Devices from Bayer in Radiology
Sep 10, 2025 • PR Newswire
Bayer leitet Wechsel des Abschlussprüfers ein
Sep 9, 2025 • Bayer
3 things you’ll only learn at the SAP Emarsys Loyalty Masterclass
Sep 9, 2025 • MarTech
Bayer supervisory board planning to propose PwC as auditor from 2027 at annual stockholders' meeting
Sep 9, 2025 • MarketScreener
Tata Elxsi and Bayer open global radiology technology centre in Pune
Sep 9, 2025 • Techcircle
ValGenesis Announces First ValConnect Innovation Day 2025 in Princeton, NJ
Sep 9, 2025 • Business Wire
Top biotech deals in August 2025
Sep 9, 2025 • Labiotech.eu
Bayer startet mit Bayer Co.Lab AdVenture Platform globales Investitionsnetzwerk in China zur Förderung von Innovationen im Bereich Biotechnologie
Sep 8, 2025 • Bayer
Bayer says elinzanetant demonstrates long-term safety and efficacy in Oasis-3 Phase III trial
Sep 8, 2025 • MarketScreener
Bayer launches Co.Lab AdVenture platform in China to accelerate biotech innovation
Sep 8, 2025 • MarketScreener
Merck KGaA names new R&D chief as it doubles down on Africa growth
Sep 3, 2025 • Pharma Letter
Merck names new R&D chief for healthcare business
Sep 3, 2025 • pharmaphorum
FDA’s New Radiopharma Guidance a Greenlight for an Accelerating Space
Sep 2, 2025 • BioSpace
3 AI Stocks Disrupting Trillion-Dollar Industries
Sep 2, 2025 • The Motley Fool
Pulmonary Arterial Hypertension Market Driven by Obesity & Cardiopulmonary Disorders | Report by DataM Intelligence
Sep 2, 2025 • EIN Presswire
Bayer, Merck & Co's Heart-Failure Drug Fails to Meet Target in Late-Stage Trial
Sep 1, 2025 • Morningstar.com
Bayer: share falls after clinical trial disappoints
Sep 1, 2025 • MarketScreener
Bayer Shares Weaken Slightly After Minor Study Setback
Sep 1, 2025 • MarketScreener
Bayer, Merck & Co's Heart-Failure Drug Fails to Meet Target in Late-Stage Trial
Sep 1, 2025 • MarketScreener
Bayer Reports Mixed Clinical Trial Results for Heart Failure Treatment
Aug 31, 2025 • MarketScreener
Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension
Aug 30, 2025 • MarketScreener
Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction
Aug 30, 2025 • Business Wire
🫧 Fat-Trapping Micro Beads
Aug 29, 2025 • FoodHack Weekly
Bayer files 'safer, greener' MRI contrast agent in US
Aug 27, 2025 • pharmaphorum
Brazil soy farmers, Bayer clash over seed ’breeding incentives’
Aug 27, 2025 • Investing.com
Brazil soy farmers, Bayer clash over seed 'breeding incentives'
Aug 27, 2025 • MarketScreener
Bayer: FDA accepts NDA application
Aug 27, 2025 • MarketScreener
Bayer's Contrast Agent for MRI Scans Accepted for Review by FDA
Aug 27, 2025 • MarketScreener
Tropical Agrosystem eyes 22% revenue jump to 2,200 crore in FY26 on monsoon boost, patented products
Aug 27, 2025 • Hindu Business Line
Brazil soy farmers, Bayer clash over seed 'breeding incentives'
Aug 27, 2025 • MarketScreener
Bayer announces new drug application for gadoquatrane accepted for review by FDA
Aug 27, 2025 • thefly.com
Bayer: gadoquatrane new drug application accepted for review by U.S. FDA
Aug 27, 2025 • MarketScreener
Bayer's Contrast Agent for MRI Scans Accepted for Review by FDA
Aug 27, 2025 • Morningstar.com
Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025
Aug 25, 2025 • Business Wire
Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025
Aug 25, 2025 • MarketScreener
Merck Demonstrates Ongoing Commitment to Advancing Cardio...
Aug 25, 2025 • PharmiWeb
Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025
Aug 25, 2025 • BioSpace
Veterinary Orthobiologics Market Set to Double, Reaching USD 2.0 Billion by 2034 | Reports and Data
Aug 25, 2025 • EIN Presswire
Bayer launches Camalus to tackle sucking pests in horticulture crops
Aug 22, 2025 • Hindu Business Line
Why most AI drug discovery startups struggle — and how Turbine plans to beat the odds
Aug 22, 2025 • Tech.eu
Agricultural Pheromone Market Poised for Growth, Expected to Hit USD 11.38 Billion by 2032 | Coherent Market Insights
Aug 22, 2025 • Coherent Market Insights Pvt. Ltd
Bayer will invest US$43 million in its production plant in Veracruz
Aug 22, 2025 • MEXICONOW
Calcium Citrate Market is Booming Worldwide According to New Research Report Forecast to 2031
Aug 22, 2025 • EIN Presswire
Health Canada grants marketing authorization for an additional indication of Bayer's NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) Français
Aug 21, 2025 • Canada NewsWire
Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program
Aug 21, 2025 • AgTech Breakthrough
LANXESS scouting for new North American HQ in region
Aug 21, 2025 • Seattle TechFlash
Dicamba Herbicide Market to Grow at 6.1% CAGR Through 2031, Fueled by Weed Resistance and Crop Adoption
Aug 21, 2025 • EIN Presswire